Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 539Neoplasms 482Carcinoma, Non-Small-Cell Lung 395Prostatic Neoplasms 314Colorectal Neoplasms 300Lung Neoplasms 265Neoplasm Metastasis 222Ovarian Neoplasms 199Leukemia, Myeloid, Acute 197Pancreatic Neoplasms 187Multiple Myeloma 174Recurrence 135Squamous Cell Carcinoma of Head and Neck 133Stomach Neoplasms 131Brain Neoplasms 131Melanoma 127Carcinoma, Hepatocellular 126Glioblastoma 121Endometrial Neoplasms 121Triple Negative Breast Neoplasms 113Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Hematologic Neoplasms 104Head and Neck Neoplasms 100Carcinoma, Renal Cell 98Lymphoma 96Urinary Bladder Neoplasms 93Sarcoma 91Glioma 88Rectal Neoplasms 83Small Cell Lung Carcinoma 82

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Gaucher Disease × 90 days × Clear all
NCT03721068 2026-03-27

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
18 enrolled
CNSSarcoma

Gaucher Disease, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡